Brown, Lisle/Cummings’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.34M Buy
7,110
+234
+3% +$84K 0.58% 43
2025
Q4
$2.42M Hold
6,876
0.6% 44
2025
Q3
$2.54M Hold
6,876
0.65% 41
2025
Q2
$2.72M Hold
6,876
0.72% 38
2025
Q1
$2.56M Buy
6,876
+308
+5% +$117K 0.74% 39
2024
Q4
$2.36M Buy
6,568
+182
+3% +$67.4K 0.71% 38
2024
Q3
$2.31M Buy
6,386
+1,175
+23% +$406K 0.7% 34
2024
Q2
$1.77M Buy
5,211
+275
+6% +$93.2K 0.58% 46
2024
Q1
$1.77M Hold
4,936
0.6% 43
2023
Q4
$1.48M Sell
4,936
-13
-0.3% -$3.65K 0.55% 45
2023
Q3
$1.35M Buy
4,949
+685
+16% +$196K 0.61% 43
2023
Q2
$1.3M Buy
4,264
+685
+19% +$198K 0.58% 44
2023
Q1
$1.02M Hold
3,579
0.52% 48
2022
Q4
$875K Buy
3,579
+333
+10% +$75.6K 0.47% 53
2022
Q3
$657K Buy
3,246
+25
+0.8% +$5.26K 0.38% 65
2022
Q2
$641K Buy
3,221
+157
+5% +$36.9K 0.35% 70
2022
Q1
$819K Buy
3,064
+1,121
+58% +$290K 0.39% 63
2021
Q4
$520K Buy
+1,943
New +$510K 0.26% 95

Other funds holding SYK

Brown, Lisle/Cummings's SYK Position: Q1 2026 in Review

Brown, Lisle/Cummings increased its Stryker (SYK) stake by 3.4% in Q1 2026, buying an estimated $84K and bringing the position to 7,110 shares worth $2.34M. The position accounts for 0.58% of the portfolio, ranked #43.

Brown, Lisle/Cummings first reported a position in SYK in Q4 2021 and has held it in 18 quarters since. The position peaked at $2.72M in Q2 2025. 2,293 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Brown, Lisle/Cummings held 7,110 shares of Stryker worth $2.34M as of Q1 2026.
  • Brown, Lisle/Cummings bought 234 Stryker shares in Q1 2026, an estimated $84K.
  • Stryker made up 0.58% of Brown, Lisle/Cummings's portfolio in Q1 2026, its #43 holding.
  • Brown, Lisle/Cummings first reported a position in Stryker in Q4 2021 and has held it in 18 quarters since.
  • Brown, Lisle/Cummings's Stryker position peaked at $2.72M in Q2 2025.
  • 2,293 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Brown, Lisle/Cummings's 13F filing for Q1 2026, filed 20 Apr 2026.